| Dr Amanda S Bruegl, MD | |
|
3181 Sw Sam Jackson Park Rd, L466, Portland, OR 97239-3011 | |
| (503) 418-4500 | |
| (503) 494-4473 |
| Full Name | Dr Amanda S Bruegl |
|---|---|
| Gender | Female |
| Speciality | Gynecological Oncology |
| Experience | 17 Years |
| Location | 3181 Sw Sam Jackson Park Rd, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700080785 | NPI | - | NPPES |
| 8DU092 | Other | TX | BCBS (MDACC) |
| 319718801 (MDACC) | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | MD171824 (Oregon) | Primary |
| 207V00000X | Obstetrics & Gynecology | MD171824 (Oregon) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohsu Hospital And Clinics | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Health And Sciences University/university Medical Group | 4880760107 | 1485 |
| Salem Health | 8628986668 | 387 |
News Archive
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that the Company has received provisional anti-trust approval from the United States Federal Trade Commission (FTC) for the proposed sale of MDS Analytical Technologies to Danaher Corporation.
Potentially lethal heart conditions may become easier to spot and may lead to improvements in prevention and treatment thanks to innovative new software that measures electrical activity in the organ.
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis headquartered in Odense, Denmark.
Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance Repligen's spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA).
A new study reveals that American high school students are unlikely to be heavy smokers, but casual and occasional smoking is on the rise. The study warns that even light smoking may be injurious to health.
› Verified 1 days ago
| Entity Name | Salem Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265431829 PECOS PAC ID: 8628986668 Enrollment ID: O20040309001131 |
News Archive
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that the Company has received provisional anti-trust approval from the United States Federal Trade Commission (FTC) for the proposed sale of MDS Analytical Technologies to Danaher Corporation.
Potentially lethal heart conditions may become easier to spot and may lead to improvements in prevention and treatment thanks to innovative new software that measures electrical activity in the organ.
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis headquartered in Odense, Denmark.
Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance Repligen's spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA).
A new study reveals that American high school students are unlikely to be heavy smokers, but casual and occasional smoking is on the rise. The study warns that even light smoking may be injurious to health.
› Verified 1 days ago
| Entity Name | University Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that the Company has received provisional anti-trust approval from the United States Federal Trade Commission (FTC) for the proposed sale of MDS Analytical Technologies to Danaher Corporation.
Potentially lethal heart conditions may become easier to spot and may lead to improvements in prevention and treatment thanks to innovative new software that measures electrical activity in the organ.
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis headquartered in Odense, Denmark.
Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance Repligen's spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA).
A new study reveals that American high school students are unlikely to be heavy smokers, but casual and occasional smoking is on the rise. The study warns that even light smoking may be injurious to health.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda S Bruegl, MD 3181 Sw Sam Jackson Park Rd, L466, Portland, OR 97239-3011 Ph: (503) 418-4500 | Dr Amanda S Bruegl, MD 3181 Sw Sam Jackson Park Rd, L466, Portland, OR 97239-3011 Ph: (503) 418-4500 |
News Archive
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that the Company has received provisional anti-trust approval from the United States Federal Trade Commission (FTC) for the proposed sale of MDS Analytical Technologies to Danaher Corporation.
Potentially lethal heart conditions may become easier to spot and may lead to improvements in prevention and treatment thanks to innovative new software that measures electrical activity in the organ.
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis headquartered in Odense, Denmark.
Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance Repligen's spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA).
A new study reveals that American high school students are unlikely to be heavy smokers, but casual and occasional smoking is on the rise. The study warns that even light smoking may be injurious to health.
› Verified 1 days ago
Dr. Rachel L Gutfreund, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10101 Se Main St Ste 3001, Portland, OR 97216 Phone: 503-261-4423 Fax: 503-261-4424 | |
John Gilbert Buckmaster, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4200 | |
Darlene J Dodson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9205 Sw Barnes Rd Fl 3, Portland, OR 97225 Phone: 503-216-3388 | |
Antonio E Frias, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-418-4200 Fax: 503-494-4473 | |
Sig-linda Jacobson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5006 Sw Martha St, Portland, OR 97221 Phone: 503-806-7854 | |
Laila Raad Sillay, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9555 Sw Barnes Rd Ste 360, Portland, OR 97225 Phone: 503-445-0590 | |
Edward Paul Kirk, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4500 |